Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes

M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology September 1979, 16 (2) 643-655;
M. NORDQVIST
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, MD 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. R. THAKKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. LEVIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. YAGI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. E. RYAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. E. THOMAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. H. CONNEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. M. JERINA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 16 no. 2 643-655
PubMed 
514264

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online September 1, 1979.

Copyright & Usage 
Copyright © 1979 by Academic Press, Inc.

Author Information

  1. M. NORDQVIST,
  2. D. R. THAKKER,
  3. W. LEVIN,
  4. H. YAGI,
  5. D. E. RYAN,
  6. P. E. THOMAS,
  7. A. H. CONNEY, and
  8. D. M. JERINA
  1. Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, MD 20014
  2. Department of Biochemistry and Drug Metabolism, Hoffmann-La Roche Inc., Nutley, NJ07110

Statistics from Altmetric.com

Article usage

Article usage: September 2005 to May 2023

AbstractFullPdf
Sep 2005101
Nov 2005100
Feb 2006002
Mar 2006201
May 2006100
Jun 2006101
Jul 2006100
Oct 2006200
Nov 2006100
Jan 2007400
Mar 2007300
Apr 2007101
Jun 2007300
Jul 2007102
Aug 2007102
Oct 2007001
Nov 2007100
Dec 2007002
Mar 2008300
Apr 2008100
May 2008100
Jun 2008200
Aug 2008100
Sep 2008300
Oct 2008502
Nov 2008600
Dec 2008600
Jan 2009300
Feb 2009800
Mar 2009200
Aug 2009200
Sep 2009600
Oct 2009500
Nov 20091100
Dec 2009600
Jan 2010100
Feb 2010200
Mar 2010200
Apr 2010400
Jul 2010201
Oct 2010201
Jan 2011100
Feb 2011900
Mar 2011400
Apr 2011402
May 2011200
Jun 2011600
Jul 2011200
Aug 2011200
Sep 2011301
Nov 2011701
Dec 2011002
Feb 2012401
Mar 2012800
Apr 2012100
May 2012801
Jun 2012600
Jul 2012300
Aug 2012200
Sep 2012202
Oct 2012401
Nov 2012300
Dec 2012206
Jan 2013600
Feb 2013800
Mar 20131103
Apr 20131900
May 20132000
Jun 2013100
Aug 2013100
Sep 20133300
Oct 20131000
Nov 2013600
Dec 2013100
Jan 2014700
Feb 2014500
Mar 2014002
May 2014201
Jun 2014200
Jul 2014100
Aug 2014200
Sep 2014200
Oct 2014500
Nov 2014600
Dec 2014600
Jan 2015200
Feb 2015200
Mar 20151001
Apr 2015300
May 2015400
Jun 2015700
Jul 2015500
Aug 2015200
Sep 2015001
Oct 2015100
Dec 2015100
Jan 2016200
Feb 20161100
Mar 20161101
Apr 2016301
May 2016700
Jun 2016101
Jul 2016100
Aug 2016100
Sep 2016201
Oct 2016500
Nov 2016400
Dec 2016100
Feb 2017201
Mar 2017200
Apr 2017200
May 2017700
Jun 2017600
Jul 20171100
Aug 2017600
Sep 2017800
Oct 20171200
Nov 20171401
Dec 20171000
Jan 20181000
Feb 2018700
Mar 2018801
Apr 2018600
May 20181300
Jun 2018300
Jul 2018300
Aug 2018500
Sep 2018600
Oct 20181000
Nov 2018101
Dec 2018501
Jan 2019400
Feb 2019801
Mar 2019400
Apr 2019300
May 2019400
Jun 2019202
Jul 2019400
Aug 2019400
Sep 2019300
Oct 20191101
Nov 2019400
Dec 2019600
Jan 2020101
Feb 2020500
Mar 2020100
Apr 2020200
May 2020100
Jun 2020200
Jul 2020400
Sep 2020100
Oct 2020900
Nov 2020700
Dec 2020300
Jan 2021600
Feb 2021600
Mar 2021900
Apr 2021300
May 20213100
Jun 2021600
Jul 2021600
Aug 2021400
Sep 2021400
Oct 2021700
Nov 20211400
Dec 2021400
Jan 20221100
Feb 2022600
Mar 2022400
Apr 20221200
May 2022400
Jun 20221200
Jul 20221300
Aug 2022400
Sep 2022400
Oct 2022500
Nov 2022702
Dec 2022200
Jan 2023400
Feb 2023300
Mar 2023500
Apr 2023400
May 2023400

PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 16, Issue 2
1 Sep 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes

M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology September 1, 1979, 16 (2) 643-655;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Highly Tumorigenic 3,4-Dihydrodiol Is a Principal Metabolite Formed from Dibenzo[a,h]anthracene by Liver Enzymes

M. NORDQVIST, D. R. THAKKER, W. LEVIN, H. YAGI, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology September 1, 1979, 16 (2) 643-655;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics